In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats
In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator (Tc-99m-rt-PA) was studied in control rats and thrombus-bearing rats. To compare fibrin bindingin vivo with thatin vitro, Tc-99m-rt-PA binding to fibrin gelin vitro was also imaged.
Rapid blood clearance and accumulation into the liver and kidneys were observed in both control and thrombus-bearing rats. Accumulation in the stomach, which indicates instability of labeled rt-PAin vivo, was very low until two hours after injection. Tc-99m-rt-PA accumulation in the clots was higher than that in skeletal and heart muscles, although it was lower than in blood, liver, and kidneys. Administration of aprotinin, an antifibrinolytic agent, significantly prolonged clot accumulation of Tc-99m-rt-PA at 30 minutes after injection. These results suggest that fibrinolysis is responsible for the low rt-PA concentration in the clots. A scintigram of a thrombus-bearing rat demonstrated increased radioactivity at the clot forming site. On the other hand, Tc-99m-labeled human albumin, which was used as a control, was not accumulated in the clot. Tc-99m-rt-PA binding to fibrin gelin vitro was clearly imaged.
By comparison,in vivo fibrin binding of Tc-99m-rt-PA was much lower thanin vitro. The reasons for low thrombus uptakein vivo may be: 1. biochemical inactivation of extrinsically administered rt-PA by t-PA inhibitor. 2. fibrinolysis by rt-PA activated plasminogen. Overcoming these limitations will enable Tc-99m-rt-PA to reach the stage of clinical trials.
Key wordsrecombinant tissue-type plasminogen activator (rt-PA) Tc-99m labeling biodistribution thrombus imaging
- 1.Health and Welfare Statistics Association: Dynamic statistics of population (Jinkou doutai toukei).J Health and Welfare Statistics 37(9): 388–411, 1990 (in Japanese)Google Scholar
- 2.Gallus AS, Hirsh J, Hull R, et al: Diagnosis of venous thromboembolism.Semin Throm Hem 2: 203–231, 1976Google Scholar
- 10.Knight LC: Do we finally have a radiopharmaceutical for rapid, specific imaging of venous thrombosis?J Nucl Med 33: 791–795, 1991Google Scholar
- 12.Hoylayaerts M, Rijken DC, Lijnen HR, et al: Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.J Biol Chem 257: 2912–2919, 1982Google Scholar
- 13.DeBoer AC, Pauluama JH, Cox PH, et al: Tc-99m labeled plasminogen activator (PA) for the diagnosis of deep vein thrombosis [Abstract].Thromb Haemostas 50: 159, 1983Google Scholar
- 15.Hnatowith DJ, Virzi F, Doherty PW, et al: Characterization of indium-111-labeled recombinant tissue plasminogen activator for the imaging of thrombi. EurJ Nucl Med 13: 467–473, 1987Google Scholar
- 17.Korninger C, Stassen JM, Collen D: Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits.Thromb Haemosta 46: 658–661, 1981Google Scholar
- 18.Nilsson T, Wallen P, Mellbring G:In vivo metabolism of human tissue plasminogen activator.Scan J Haematol 33: 49–53, 1984Google Scholar
- 20.Emeis JJ, van den Hoogen CM, Jense D: Hepatic clearance of tissue-type plasminogen activator in rats.Thromb Haemosta 54: 661–664, 1985Google Scholar
- 21.Closel JP, Banken L, Roux S: Aprotinin: An anti- dote for recombinant tissue-type plasminogen activator (rt-PA) activein vivo.JACC 16: 507–510, 1990Google Scholar
- 23.Verheijen JH, Chang GTG, Kluft C: Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.Throm Haemostas 51: 392–395, 1984Google Scholar
- 26.Fry ETA, Mack DL, Monge JC, et al: Labeling of human clotsin vitro with an active-site mutant of t-PA.J Nucl Med 30: 187–191, 1990Google Scholar
- 29.Coleman P, Kettner C, Shaw E: Inactivation of the plasminogen activator from HeCa cells by peptides of arginine chloromethyl ketoneBiochem Biolphys Acta 569: 41–51, 1979Google Scholar
- 32.Korninger C, Collewn D: Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal speciesin vitro.Thromb Haemostas 46: 561–565, 1981Google Scholar